These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3131381)

  • 1. Two distinct pathophysiological mechanisms in congenital nephrogenic diabetes insipidus.
    Moses AM; Miller JL; Levine MA
    J Clin Endocrinol Metab; 1988 Jun; 66(6):1259-64. PubMed ID: 3131381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic and coagulation responses to 1-desamino[8-D-arginine] vasopressin in patients with congenital nephrogenic diabetes insipidus.
    Bichet DG; Razi M; Lonergan M; Arthus MF; Papukna V; Kortas C; Barjon JN
    N Engl J Med; 1988 Apr; 318(14):881-7. PubMed ID: 2965301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1-Desamino-8-D-arginine vasopressin (DDAVP) in patients with congenital nephrogenic diabetes insipidus.
    Brink HS; Derkx FH; Boomsma F; Brommer EJ; Schalekamp MA
    Neth J Med; 1993 Aug; 43(1-2):5-12. PubMed ID: 8232694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normal response of factor VIII and von Willebrand factor to 1-deamino-8D-arginine vasopressin in nephrogenic diabetes insipidus.
    Brenner B; Seligsohn U; Hochberg Z
    J Clin Endocrinol Metab; 1988 Jul; 67(1):191-3. PubMed ID: 3132483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normal hemodynamic and coagulation responses to 1-deamino-8-D-arginine vasopressin in a case of lithium-induced nephrogenic diabetes insipidus. Results of treatment by a prostaglandin synthesis inhibitor (indomethacin).
    Hober C; Vantyghem MC; Racadot A; Cappoen JP; Lefebvre J
    Horm Res; 1992; 37(4-5):190-5. PubMed ID: 1490662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrinolytic responses to 1-desamino-8-D-arginine-vasopressin in patients with congenital nephrogenic diabetes insipidus.
    Knoers N; Brommer EJ; Willems H; van Oost BA; Monnens LA
    Nephron; 1990; 54(4):322-6. PubMed ID: 2109264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normal homeostasis of fibrinolysis in nephrogenic diabetes insipidus in spite of defective V2- receptor-mediated responses of tissue plasminogen activator release.
    Brommer EJ; Brink H; Derkx FH; Schalekamp MA; Stibbe J
    Eur J Clin Invest; 1990 Feb; 20(1):72-8. PubMed ID: 2138555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A variant of nephrogenic diabetes insipidus: V2 receptor abnormality restricted to the kidney.
    Knoers N; Monnens LA
    Eur J Pediatr; 1991 Mar; 150(5):370-3. PubMed ID: 1828422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epinephrine and dDAVP administration in patients with congenital nephrogenic diabetes insipidus. Evidence for a pre-cyclic AMP V2 receptor defective mechanism.
    Bichet DG; Razi M; Arthus MF; Lonergan M; Tittley P; Smiley RK; Rock G; Hirsch DJ
    Kidney Int; 1989 Nov; 36(5):859-66. PubMed ID: 2559238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absent factor VIII response to synthetic vasopressin analogue (DDAVP) in nephrogenic diabetes insipidus.
    Kobrinsky NL; Doyle JJ; Israels ED; Winter JS; Cheang MS; Walker RD; Bishop AJ
    Lancet; 1985 Jun; 1(8441):1293-4. PubMed ID: 2860491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of responsiveness to 1-desamino-D arginin vasopressin (desmopressin) in male patients with nephrogenic syndrome of inappropriate antidiuresis: from bench to bedside.
    Vandergheynst F; Pradier O; Beukinga I; Kornreich A; Vassart G; Decaux G
    Eur J Clin Invest; 2012 Mar; 42(3):254-9. PubMed ID: 21834801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Congenital nephrogenic diabetes insipidus].
    Thibonnier M
    Rev Prat; 1994 May; 44(9):1169-72. PubMed ID: 7939338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of urine volume to the elevated urinary prostaglandin E in Bartter's syndrome and central and nephrogenic diabetes insipidus.
    Fichman M; Zia P; Zipser R
    Adv Prostaglandin Thromboxane Res; 1980; 7():1193-7. PubMed ID: 7369030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autosomal recessive nephrogenic diabetes insipidus caused by an aquaporin-2 mutation.
    Hochberg Z; Van Lieburg A; Even L; Brenner B; Lanir N; Van Oost BA; Knoers NV
    J Clin Endocrinol Metab; 1997 Feb; 82(2):686-9. PubMed ID: 9024277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications.
    Michiels JJ; van de Velde A; van Vliet HH; van der Planken M; Schroyens W; Berneman Z
    Semin Thromb Hemost; 2002 Apr; 28(2):111-32. PubMed ID: 11992235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antidiuretic and PGE2 responses to AVP and dDAVP in subjects with central and nephrogenic diabetes insipidus.
    Moses AM; Scheinman SJ; Schroeder ET
    Am J Physiol; 1985 Mar; 248(3 Pt 2):F354-9. PubMed ID: 3856399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DDAVP infusion in haemophilia A carriers: different behaviour of plasma factor VIII and von Willebrand factor.
    Casonato A; Dannhauser D; Pontara E; Bertomoro A; Orazi B; Santarossa L; Zerbinati P; Girolami A
    Blood Coagul Fibrinolysis; 1996 Jul; 7(5):549-53. PubMed ID: 8874865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proposed cause of marked vasopressin resistance in a female with an X-linked recessive V2 receptor abnormality.
    Moses AM; Sangani G; Miller JL
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1184-6. PubMed ID: 7714087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary adenosine 3',5'-monophosphate (cAMP) response to antidiuretic hormone in diabetes insipidus (DI): comparison between congenital nephrogenic DI type 1 and 2, and vasopressin sensitive DI.
    Ohzeki T
    Acta Endocrinol (Copenh); 1985 Apr; 108(4):485-90. PubMed ID: 2986401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for intact V1-vasopressin receptors in congenital nephrogenic diabetes insipidus.
    Knoers N; Janssens PM; Goertz J; Monnens LA
    Eur J Pediatr; 1992 May; 151(5):381-3. PubMed ID: 1396896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.